What's new

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised

Mar 4, 2025 - 16:10
 0
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised
Human medicines European public assessment report (EPAR): SomaKit TOC, edotreotide, Date of authorisation: 08/12/2016, Revision: 20, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Toviaz, fesoterodine, ...

Next Article

Nordstrom Q4 comparable sales beat expectations, CFO departs

Related Posts

Orphan designation: autologous T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 Treatment of myasthenia gravis, 20/02/2025 Positive

Orphan designation: autologous T cells transduced with ...

Mar 12, 2025  0

Real-world evidence

Real-world evidence

Apr 3, 2025  0

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 11, 2025  0